|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"jen chung ko"
Showing items 16-40 of 61 (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2019-12-18T06:15:22Z |
Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations
|
Yang, James Chih-Hsin; Shih, Jin-Yuan;SHENG KAI LIANG;JEN-CHUNG KO; JEN-CHUNG KO; SHENG KAI LIANG; Yang, James Chih-Hsin; Shih, Jin-Yuan |
| 臺大學術典藏 |
2019-12-18T06:15:22Z |
Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study
|
MENG RUI LEE;Chih-Hsin Lee; Jann-Yuan Wang; Shih-Wei Lee; Li-Na Lee;JEN-CHUNG KO; JEN-CHUNG KO; Chih-Hsin Lee; Jann-Yuan Wang; Shih-Wei Lee; Li-Na Lee; MENG RUI LEE |
| 臺大學術典藏 |
2019-12-18T06:15:22Z |
Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study
|
MENG RUI LEE;Chih-Hsin Lee; Jann-Yuan Wang; Shih-Wei Lee; Li-Na Lee;JEN-CHUNG KO; JEN-CHUNG KO; Chih-Hsin Lee; Jann-Yuan Wang; Shih-Wei Lee; Li-Na Lee; MENG RUI LEE |
| 臺大學術典藏 |
2019-12-18T06:15:22Z |
Capsaicin enhances erlotinib-induced cytotoxicity: Via AKT inactivation and excision repair cross-complementary 1 (ERCC1) down-regulation in human lung cancer cells
|
JEN-CHUNG KO; Chen, Jyh-Cheng; Yen, Ting-Chuan; Chen, Tzu-Ying; Lin, Yuan-Cheng; Ma, Peng-Fang; Lin, Yun-Wei |
| 臺大學術典藏 |
2019-12-18T06:15:22Z |
Nitroglycerin Enhances Cisplatin-Induced Cytotoxicity via AKT Inactivation and Thymidylate Synthase Downregulation in Human Lung Cancer Cells
|
Chen, J.-C.; Yen, T.-C.; Chen, T.-Y.; Ma, P.-F.; Lin, Y.-C.; Cheng, H.-H.; Taso, Y.-C.; Lin, Y.-W.; JEN-CHUNG KO; Chen, J.-C.; Yen, T.-C.; Chen, T.-Y.; Ma, P.-F.; Lin, Y.-C.; Cheng, H.-H.; Taso, Y.-C.; Lin, Y.-W.;JEN-CHUNG KO |
| 臺大學術典藏 |
2019-12-18T06:15:22Z |
Nitroglycerin Enhances Cisplatin-Induced Cytotoxicity via AKT Inactivation and Thymidylate Synthase Downregulation in Human Lung Cancer Cells
|
Chen, J.-C.; Yen, T.-C.; Chen, T.-Y.; Ma, P.-F.; Lin, Y.-C.; Cheng, H.-H.; Taso, Y.-C.; Lin, Y.-W.; JEN-CHUNG KO; Chen, J.-C.; Yen, T.-C.; Chen, T.-Y.; Ma, P.-F.; Lin, Y.-C.; Cheng, H.-H.; Taso, Y.-C.; Lin, Y.-W.;JEN-CHUNG KO |
| 臺大學術典藏 |
2019-12-18T06:15:22Z |
Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study
|
JEN-CHUNG KO; Wei, Yu-Feng; Huang, Wen-Tsung; Liu, Tu-Chen; Shieh, Jiunn-Min; Chian, Chih-Feng; Wu, Ming-Fang; Chang, Chih-Cheng; Lin, Ching-Hsiung; Lin, Chia-Mo; Hsia, Te-Chun |
| 臺大學術典藏 |
2019-12-18T06:15:21Z |
Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study
|
MENG RUI LEE;Liu, Tsung-Hao; Tsai, Jaw-Shiun; Wang, Jann-Yuan;HUNG YANG KUO;KAI LUN YU;JEN-CHUNG KO; JEN-CHUNG KO; KAI LUN YU; HUNG YANG KUO; Liu, Tsung-Hao; Tsai, Jaw-Shiun; Wang, Jann-Yuan; MENG RUI LEE |
| 臺大學術典藏 |
2019-12-18T06:15:21Z |
Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study
|
MENG RUI LEE;Liu, Tsung-Hao; Tsai, Jaw-Shiun; Wang, Jann-Yuan;HUNG YANG KUO;KAI LUN YU;JEN-CHUNG KO; JEN-CHUNG KO; KAI LUN YU; HUNG YANG KUO; Liu, Tsung-Hao; Tsai, Jaw-Shiun; Wang, Jann-Yuan; MENG RUI LEE |
| 臺大學術典藏 |
2019-09-16T09:25:32Z |
Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study
|
JEN-CHUNG KO;Liu, Tu Chen;Hsia, Te Chun;Lin, Ching Hsiung;Chang, Chih Cheng;Wei, Yu Feng;Wu, Ming Fang;Chian, Chih Feng;Lin, Chia Mo;Shieh, Jiunn Min;Huang, Wen Tsung; Huang, Wen Tsung; Shieh, Jiunn Min; Lin, Chia Mo; Chian, Chih Feng; Wu, Ming Fang; Wei, Yu Feng; Chang, Chih Cheng; Lin, Ching Hsiung; Hsia, Te Chun; Liu, Tu Chen; JEN-CHUNG KO |
| 臺大學術典藏 |
2019-09-16T09:25:32Z |
Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study
|
JEN-CHUNG KO;Liu, Tu Chen;Hsia, Te Chun;Lin, Ching Hsiung;Chang, Chih Cheng;Wei, Yu Feng;Wu, Ming Fang;Chian, Chih Feng;Lin, Chia Mo;Shieh, Jiunn Min;Huang, Wen Tsung; Huang, Wen Tsung; Shieh, Jiunn Min; Lin, Chia Mo; Chian, Chih Feng; Wu, Ming Fang; Wei, Yu Feng; Chang, Chih Cheng; Lin, Ching Hsiung; Hsia, Te Chun; Liu, Tu Chen; JEN-CHUNG KO |
| 臺大學術典藏 |
2019-03-04T08:06:47Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: a real-world, large cohort study
|
Sheng-Kai Liang;Meng-Rui Lee;Wei-Yu Liao;Chao-Chi Ho;Jen-Chung Ko;Jin-Yuan Shih; SHENG-KAI LIANG; MENG-RUI LEE; WEI-YU LIAO; CHAO-CHI HO; JEN-CHUNG KO; JIN-YUAN SHIH |
| 臺大學術典藏 |
2019-03-04T08:06:47Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: a real-world, large cohort study
|
Sheng-Kai Liang;Meng-Rui Lee;Wei-Yu Liao;Chao-Chi Ho;Jen-Chung Ko;Jin-Yuan Shih; SHENG-KAI LIANG; MENG-RUI LEE; WEI-YU LIAO; CHAO-CHI HO; JEN-CHUNG KO; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T18:07:07Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang, S.-K. and Lee, M.-R. and Liao, W.-Y. and Ho, C.-C. and Ko, J.-C. and Shih, J.-Y.; MENG RUI LEE; Wei-Yu Liao; Chao-Chi Ho; Jin-Yuan Shih; JEN-CHUNG KO; SHENG-KAI LIANG |
| 臺大學術典藏 |
2018-09-10T18:06:04Z |
Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
|
Liang, S.-K. and Hsieh, M.-S. and Lee, M.-R. and Keng, L.-T. and Ko, J.-C. and Shih, J.-Y.; MENG-RUI LEE; KENG LI-TA; JEN-CHUNG KO; SHENG-KAI LIANG; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T18:04:18Z |
Diabetes Mellitus and Latent Tuberculosis Infection: A Systemic Review and Metaanalysis
|
Lee, M.-R. and Huang, Y.-P. and Kuo, Y.-T. and Luo, C.-H. and Shih, Y.-J. and Shu, C.-C. and Wang, J.-Y. and Ko, J.-C. and Yu, C.-J. and Lin, H.-H.; CHIN-CHUNG SHU; Chong-Jen Yu; MENG-RUI LEE; JANN-YUAN WANG; HSIEN-HO LIN; JEN-CHUNG KO |
| 臺大學術典藏 |
2018-09-10T18:03:16Z |
Psychological distress and coping strategies among women with incurable lung cancer: a qualitative study
|
Liao, Y.-C. and Liao, W.-Y. and Sun, J.-L. and Ko, J.-C. and Yu, C.-J.; CHONG-JEN YU; WEI-YU LIAO; JEN-CHUNG KO |
| 臺大學術典藏 |
2018-09-10T18:01:48Z |
Gefitinib or erlotinib in previously treated non-small-cell lung cancer patients: A cohort study in Taiwan
|
Chang, C.-H. and Lee, C.-H. and Ko, J.-C. and Chang, L.-Y. and Lee, M.-C. and Wang, J.-Y. and Yu, C.-J.; Chong-Jen Yu; JANN-YUAN WANG; CHIA-HAO CHANG; JEN-CHUNG KO; LIH-YU CHANG |
| 臺大學術典藏 |
2018-09-10T15:34:32Z |
Acquisition of Mycobacterium abscessus among ventilator-dependent patients in Taiwan chronic respiratory care facilities
|
Lee, M.-R. and Tsai, C.-J. and Hu, J.-Y. and Lee, S.-W. and Ko, J.-C. and Wang, H.-C. and Yu, C.-J. and Lee, L.-N. and Hsueh, P.-R.; PO-REN HSUEH; LI-NA LEE; Chong-Jen Yu; MENG-RUI LEE; HAO-CHIEN WANG; JEN-CHUNG KO |
| 臺大學術典藏 |
2018-09-10T15:34:32Z |
Cementing an unwanted relationship
|
KENG LI-TA; JEN-CHUNG KO; CHIA-HAO CHANG; Chang, C.-H. and Keng, L.-T. and Ko, J.-C. |
| 臺大學術典藏 |
2018-09-10T15:34:32Z |
Salinomycin enhances cisplatin-induced cytotoxicity in human lung cancer cells via down-regulation of AKT-dependent thymidylate synthase expression
|
Ko, J.-C. and Zheng, H.-Y. and Chen, W.-C. and Peng, Y.-S. and Wu, C.-H. and Wei, C.-L. and Chen, J.-C. and Lin, Y.-W.; JEN-CHUNG KO; Zheng, Hao-Yu; Chen, Wen-Ching; Peng, Yi-Shuan; Wu, Chia-Hung; Wei, Chia-Li; Chen, Jyh-Cheng; Lin, Yun-Wei |
| 臺大學術典藏 |
2018-09-10T15:34:30Z |
Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells
|
Pan, C.-H. and Chang, Y.-F. and Lee, M.-S. and Wen, B.-C. and Ko, J.-C. and Liang, S.-K. and Liang, M.-C.; Pan, Chun-Hao; Chang, Ying-Fang; Lee, Ming-Shuo; Wen, B-Chen; Liang, Mei-Chih; JEN-CHUNG KO; SHENG-KAI LIANG |
| 臺大學術典藏 |
2018-09-10T15:32:36Z |
Astaxanthin down-regulates Rad51 expression via inactivation of AKT kinase to enhance mitomycin C-induced cytotoxicity in human non-small cell lung cancer cells
|
Jen-Chung Ko and Jyh-Cheng Chen and Tai-Jing Wang and Hao-Yu Zheng and Wen-Ching Chen and Po-Yuan Chang and Yun-Wei Lin; JEN-CHUNG KO; Chen, Jyh-Cheng; Wang, Tai-Jing; Zheng, Hao-Yu; Chen, Wen-Ching; Chang, Po-Yuan; Lin, Yun-Wei |
| 臺大學術典藏 |
2018-09-10T15:19:23Z |
Resveratrol Enhances Etoposide-Induced Cytotoxicity through Down-Regulating ERK1/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC1) Protein Expression in Human Non-Small-Cell Lung Cancer Cells
|
Ko, J.-C. and Syu, J.-J. and Chen, J.-C. and Wang, T.-J. and Chang, P.-Y. and Chen, C.-Y. and Jian, Y.-T. and Jian, Y.-J. and Lin, Y.-W.; JEN-CHUNG KO; Syu, Jhan-Jhang; Chen, Jyh-Cheng; Wang, Tai-Jing; Chang, Po-Yuan; Chen, Chien-Yu; Jian, Yun-Ting; Jian, Yi-Jun; Lin, Yun-Wei |
| 臺大學術典藏 |
2018-09-10T15:19:23Z |
Down-regulation of MSH2 expression by Hsp90 inhibition enhances cytotoxicity affected by tamoxifen in human lung cancer cells
|
Ko, J.-C. and Chiu, H.-C. and Syu, J.-J. and Chen, C.-Y. and Jian, Y.-T. and Huang, Y.-J. and Wo, T.-Y. and Jian, Y.-J. and Chang, P.-Y. and Wang, T.-J. and Lin, Y.-W.; JEN-CHUNG KO; hiu, Hsien-Chun; Syu, Jhan-Jhang; Chen, Chien-Yu; Jian, Yun-Ting; Huang, Yi-Jhen; Wo, Ting-Yu; Jian, Yi-Jun; Chang, Po-Yuan; Wang, Tai-Jing; Lin, Yun-Wei |
Showing items 16-40 of 61 (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page
|
